Exciting news - we have another publication, and our first specifically about VALIDATE!
The VALIDATE Network Management Board have written "VALIDATE: Exploiting the synergy between complex intracellular pathogens to expedite vaccine research and development for tuberculosis, leishmaniasis, melioidosis and leprosy" as a statement of what we're aiming to achieve through VALIDATE, so take a look and pass it on to anyone you work or collaborate with in vaccine development.
Published: 23 April 2018
